Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Yale J Biol Med ; 93(2): 277-281, 2020 06.
Artigo em Inglês | MEDLINE | ID: mdl-32607088

RESUMO

Oral herpes labialis, more commonly known as cold sores, are a common encountered viral infection involving herpes simplex virus-1 (HSV-1). Although relatively benign, these lesions can be both unsightly and clinically difficult to manage. Prescription standards of care and over-the-counter agents, such as docosonal, have often shown only limited efficacy in both decreasing lesional pain and reducing duration of lesional symptomology and are not without potential side effects. Despite some success with acute remediation, recurrent episodes often occur, with seemingly no imparted protection or suppression against future outbreaks. This case report involves the successful treatment of oro-facial herpes labialis with a synergistic botanical blend with marked reduction in symptoms, pain score, and lesion duration. Monitoring and evaluation post-treatment and application during future prodromal symptoms was also performed demonstrating additional reduction in the frequency of subsequent outbreaks. This case report supports the use of this treatment for prodromal and acute treatment of oro-facial herpes infection and appears to impart a reduction in the frequency of future outbreaks.


Assuntos
Eleutherococcus , Glycyrrhiza , Herpes Labial , Hypericum , Lavandula , Melissa , Sarraceniaceae , Cicatrização/efeitos dos fármacos , Adulto , Analgésicos/farmacologia , Anti-Inflamatórios/farmacologia , Antivirais/farmacologia , Composição de Medicamentos , Feminino , Géis/farmacologia , Herpes Labial/diagnóstico , Herpes Labial/fisiopatologia , Herpes Labial/terapia , Humanos , Prevenção Secundária/métodos , Simplexvirus/efeitos dos fármacos , Resultado do Tratamento
2.
PLoS One ; 11(7): e0159857, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27458926

RESUMO

The use of botanical medicine by practitioners and the general public has dramatically increased in recent years. Most of these botanical therapeutics are obtained through commercial manufacturers or nutraceutical companies. The current standard of practice that manufacturers typically use to standardize botanicals is done based on the level of a well-known, abundant marker compound present in the botanical. This study evaluated the putative correlation between the level of a marker compound and the biological activity of eight common botanicals. Overall, the standardization of a botanical based on a marker compound was found not to be a reliable method when compared to in vitro bioactivity. A marker compound is often not the biologically active component of a plant and therefore the level of such a marker compound does not necessarily correlate with biological activity or therapeutic efficacy.


Assuntos
Anti-Infecciosos/normas , Preparações de Plantas/normas , Animais , Anti-Infecciosos/farmacologia , Candida albicans/efeitos dos fármacos , Células Cultivadas , Relação Dose-Resposta a Droga , Herpesvirus Humano 1/efeitos dos fármacos , Humanos , Preparações de Plantas/farmacologia , Valores de Referência , Staphylococcus aureus/efeitos dos fármacos , Células Vero
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...